77
[Lab] SGN survo — VendorInvestigate came back 93.7% against a claimed 94.2%
I have had 7 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied…
u/elise_ramos
Contributes reviews on supplier material. Based in Galway.
member · joined 12 Mar 2025
12,024post karma
6,650comment karma
5submissions
78comments
Overview — page 2 of 5
comment on anyone else notice Medutest kicking in around week 30 in c/labresults · 82 points · 4 months ago
Strongly agree. Below-spec results matter as much as good ones.
comment on why does nobody talk about PeptideMeter in c/labresults · 107 points · 4 months ago
Small correction: the trial was 19 weeks, not 12. Does not change your point but people will quote it.
comment on unpopular opinion: state board is massively overrated in c/compounding · 69 points · 4 months ago
Sceptical. If this were true we would see it reflected in the data and we do not.
comment on [PSA] tier 3 is not what most of this community thinks it is in c/glp1uk · 20 points · 4 months ago
This is the "correlation is mechanism" thing again. You changed three variables at once.
comment on dose stretching — 7 things I got wrong before I got it right in c/maintenancephase · 44 points · 4 months ago
Strongly agree. Lowest effective dose is a real discovery process.
comment on why does nobody talk about API source in c/compounding · 39 points · 5 months ago
the 503A/503B distinction is load-bearing, do not blur it
comment on [Discussion] can we stop arguing about pricing until somebody posts a number in c/glp1uk · 1 points · 5 months ago
source?
comment on maintenance — my 7-week log, condensed into one table in c/maintenancephase · 3 points · 5 months ago
Strongly agree. Lowest effective dose is a real discovery process.
comment on the purity thing finally clicked for me and I want to write it down in c/labresults · 12 points · 6 months ago
the 97.9% result confirmed the vendor claim, that is the signal
comment on [Lab] SGN survo — VendorInvestigate came back 93.7% against a claimed 94.2% in c/compounding · 3 points · 6 months ago
You have restated the marketing copy. What is the actual substance here.
comment on [Lab] SGN survo — VendorInvestigate came back 93.7% against a claimed 94.2% in c/compounding · 2 points · 6 months ago
API source questions are on-topic and compounders dodging them is newsworthy
comment on private prescription vs MHRA — genuinely asking which matters more in c/glp1uk · -21 points · 7 months ago
Crossposting this to c/progresspics because the people who need it are not reading this community.
comment on three years of Medutest threads, summarised so you do not have to read them in c/labresults · 4 points · 7 months ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on why does nobody talk about tier 3 in c/glp1uk · 18 points · 7 months ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on the regain question that gets asked weekly, answered properly in c/maintenancephase · 21 points · 9 months ago
the 1.0mg dose works fine for 79 weeks of the month
comment on 503B vs shortage list — genuinely asking which matters more in c/compounding · 40 points · 10 months ago
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
comment on France: tier 3, and what it actually costs here in c/glp1uk · 322 points · 11 months ago
say which nation, England, Scotland, Wales, NI differ
comment on stalled for 18 weeks at 5mg and I refuse to panic this time in c/labresults · 26 points · 1 year ago
the vial you ordered versus the vial you received might be different batches
comment on pricing: the version I wish someone had shown me in week 1 in c/glp1uk · 270 points · 1 year ago
This is correct. Private and NHS pathways are different.